BAL Pharma Consulting, Limited Liability Company
What will the market look like when an asset is at the stage of market entry?
What strategy will maximize the valuation of an asset in the "future" marketplace?
-Conduct a commercial assessment that is customized to the asset.
Consideration of market sizing/trends, competitive, reimbursement landscape, and treatment algorithm
Opinion leader, payer, and/or prescriber input on target product profile, development plan, reimbursement/pricing, positioning, IP strategy
-Build development, manufacturing, commercial, reimbursement, IP strategy, and business plan for asset.
-Develop a compelling, defendable valuation, supported with a business plan, to present to potential payers, partners, investors, and/or acquirers of asset.
Build Business Plans for Specialty Products/Portfolios.
Assess Commercial Markets, Maximize Valuation of Compounds.
Generate Defendable Custom Forecast/Valuation Models.
Advise Executive Management/Drive Process to Secure Partnering/Funding